PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,863,077 | -30.1% | 165,114 | -26.9% | 0.00% | 0.0% |
| Q2 2023 | $4,095,537 | -41.6% | 226,023 | -14.2% | 0.00% | 0.0% |
| Q1 2023 | $7,009,446 | +146.1% | 263,513 | +78.8% | 0.00% | 0.0% |
| Q4 2022 | $2,848,411 | +32.9% | 147,357 | +43.7% | 0.00% | – |
| Q3 2022 | $2,143,000 | -38.0% | 102,566 | -76.2% | 0.00% | -100.0% |
| Q2 2022 | $3,454,000 | +245.4% | 431,224 | +202.2% | 0.00% | – |
| Q1 2022 | $1,000,000 | -24.1% | 142,685 | +46.2% | 0.00% | – |
| Q4 2021 | $1,318,000 | +136.2% | 97,628 | +195.3% | 0.00% | – |
| Q3 2021 | $558,000 | -24.5% | 33,066 | +30.2% | 0.00% | – |
| Q2 2021 | $739,000 | +27.6% | 25,406 | +72.6% | 0.00% | – |
| Q1 2021 | $579,000 | +41.2% | 14,717 | -18.5% | 0.00% | – |
| Q4 2020 | $410,000 | -71.9% | 18,065 | -59.9% | 0.00% | – |
| Q2 2020 | $1,461,000 | – | 45,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |